<p>Trend and Characteristics of <em>Acinetobacter baumannii</em> Infections in Patients Attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: A Longitudinal Study of 2018</p>
Abstract:Background: Acinetobacter baumannii is one of the major organisms causing nosocomial infections and is intrinsically resistant to multiple classes of antibiotics. The main objective of this study was to investigate the trend and characteristics of A. baumannii infections including its resistance pattern among patients attending Universal College of Medical Sciences, Teaching Hospital (UCMSTH) in Western Nepal, between January and December 2018. Patients and Methods: A total of 4862 clinical samples received at… Show more
“…Of the total (253) bacterial growth, more than ninety percent were Gram-negative bacteria, E. coli was the most predominant isolates among them. Our findings are consistent with previous studies reported from Everest Hospital, Baneshwor, 14 Alka Hospital, Jawlakhel, 31 National Public Health Laboratory, Teku, 32 Universal College of Medical Sciences, Bhairahawa, 33 B.P Koirala Institute of Health Sciences, Dharan, 34 Nobel Medical College, Biratnagar, 35 New Delhi, India, 36 Al-Najaf City, Iraq, 37 Shashemene Referral Hospital, Ethiopia, 38 and Mexico City, Mexico. 39 Slightly higher rate of Gram-negative bacterial infections were observed among female patients and could be due to higher prevalence of urinary tract infections among females.…”
Background: Antibiotic resistance mediated by the production of extended-spectrum βlactamases (ESBLs) and AmpC β-lactamases is posing a serious threat in the management of the infections caused by Gram-negative pathogens. The aim of this study was to determine the prevalence of two AmpC β-lactamases genes, bla CITM and bla DHAM , in Gram-negative bacterial isolates. Materials and Methods: A total of 1151 clinical samples were obtained and processed at the microbiology laboratory of Annapurna Neurological Institute and Allied Science, Kathmandu between June 2017 and January 2018. Gram-negative isolates thus obtained were tested for antimicrobial susceptibility testing (AST) using Kirby-Bauer disk diffusion method. AmpC β-lactamase production was detected by disk approximation method using phenylboronic acid (PBA). Confirmed AmpC β-lactamase producers were further screened for bla CITM and bla DHAM genes by conventional polymerase chain reaction (PCR). Results: Out of 1151 clinical specimens, 22% (253/1152) had bacterial growth. Of the total isolates, 89.3% (226/253) were Gram-negatives, with E. coli as the most predominant species (n=72) followed by Pseudomonas aeruginosa (n=41). In the AST, 46.9% (106/226) of the Gram-negative isolates were multidrug resistant (MDR). In disk diffusion test, 113 (50%) isolates showed resistance against cefoxitin, among which 91 isolates (83 by disk test and Boronic acid test, 8 by Boronic test only) were confirmed as AmpC β-lactamase-producers. In PCR assay, 90.1% (82/91) and 87.9% (80/91) of the isolates tested positive for production of bla CITM and bla DHAM genes, respectively. Conclusions: High prevalence of AmpC β-lactamase-producers in our study is an alarming sign. This study recommends the use of modern diagnostic facilities in the clinical settings for early detection and management which can optimize the treatment therapies, curb the growth and spread of the drug-resistant pathogens.
“…Of the total (253) bacterial growth, more than ninety percent were Gram-negative bacteria, E. coli was the most predominant isolates among them. Our findings are consistent with previous studies reported from Everest Hospital, Baneshwor, 14 Alka Hospital, Jawlakhel, 31 National Public Health Laboratory, Teku, 32 Universal College of Medical Sciences, Bhairahawa, 33 B.P Koirala Institute of Health Sciences, Dharan, 34 Nobel Medical College, Biratnagar, 35 New Delhi, India, 36 Al-Najaf City, Iraq, 37 Shashemene Referral Hospital, Ethiopia, 38 and Mexico City, Mexico. 39 Slightly higher rate of Gram-negative bacterial infections were observed among female patients and could be due to higher prevalence of urinary tract infections among females.…”
Background: Antibiotic resistance mediated by the production of extended-spectrum βlactamases (ESBLs) and AmpC β-lactamases is posing a serious threat in the management of the infections caused by Gram-negative pathogens. The aim of this study was to determine the prevalence of two AmpC β-lactamases genes, bla CITM and bla DHAM , in Gram-negative bacterial isolates. Materials and Methods: A total of 1151 clinical samples were obtained and processed at the microbiology laboratory of Annapurna Neurological Institute and Allied Science, Kathmandu between June 2017 and January 2018. Gram-negative isolates thus obtained were tested for antimicrobial susceptibility testing (AST) using Kirby-Bauer disk diffusion method. AmpC β-lactamase production was detected by disk approximation method using phenylboronic acid (PBA). Confirmed AmpC β-lactamase producers were further screened for bla CITM and bla DHAM genes by conventional polymerase chain reaction (PCR). Results: Out of 1151 clinical specimens, 22% (253/1152) had bacterial growth. Of the total isolates, 89.3% (226/253) were Gram-negatives, with E. coli as the most predominant species (n=72) followed by Pseudomonas aeruginosa (n=41). In the AST, 46.9% (106/226) of the Gram-negative isolates were multidrug resistant (MDR). In disk diffusion test, 113 (50%) isolates showed resistance against cefoxitin, among which 91 isolates (83 by disk test and Boronic acid test, 8 by Boronic test only) were confirmed as AmpC β-lactamase-producers. In PCR assay, 90.1% (82/91) and 87.9% (80/91) of the isolates tested positive for production of bla CITM and bla DHAM genes, respectively. Conclusions: High prevalence of AmpC β-lactamase-producers in our study is an alarming sign. This study recommends the use of modern diagnostic facilities in the clinical settings for early detection and management which can optimize the treatment therapies, curb the growth and spread of the drug-resistant pathogens.
“…The increased and variable rate of colistin resistance may be due to quality, concentration and extensive use of colistin in the livestock farming [ 34 ]. In clinical samples, E. coli remains as the most frequently isolated organisms which is consistent with several previous studies from Nepal [ 35 – 38 ]. The higher load of E. coli in urine samples may be due to their main role in urinary tract infections [ 35 ].…”
Background
Plasmid-mediated resistance to the last-resort drugs: carbapenems and colistin is an emerging public health threat. The studies on the prevalence and co-expression of resistant genes among livestock and human pathogens are rare in Nepal. This is the first study in Nepal exploring the prevalence and co-existence of colistin resistance gene, mcr-1 along with carbapenemase resistance gene, OXA-48 in Escherichia coli isolated from poultry and clinical specimens.
Methods
A total of 240 rectal swabs from chickens of five different poultry farms of Kathmandu valley and 705 mid-stream urine samples from human subjects attending Kantipur Hospital, Kathmandu were collected between August, 2018 and March, 2019. Rectal swabs and urine specimens were cultured. E. coli isolated from the specimens were screened for antimicrobial susceptibility testing (AST) using disk diffusion method’. Minimum inhibitory concentration (MIC) of colistin was determined by agar dilution method using 0.5 µg/ml to 32 µg/ml. The E. coli isolates were first screened for mcr-1 followed by screening for OXA-48 genes using conventional Polymerase chain reaction (PCR).
Results
Of the total samples analyzed, E. coli was isolated from 31.7% (76/240) of poultry and 7.9% (56/705) of clinical specimens. In AST, 80% (61/76) of E. coli from poultry and 79% (44/56) from clinical specimens were MDR. The phenotypic prevalence of colistin resistance in poultry specimens were 31.6% (24/76) and clinical specimens were 21.4% (12/56). In PCR assay, 27.6% (21/76) of poultry and 19.6% (11/56) of clinical isolates had colistin resistant mcr-1 gene. MICs value of E. coli isolates ranged from 4 to 32 (µg/ml) in both clinical and poultry isolates. Prevalence of co-existing carbapenem resistance gene, OXA-48, among colistin resistant mcr-1 positive isolates was 38% (8/21) in poultry specimens and 18.2% (2/11) in clinical specimens.
Conclusions
The high prevalence of colistin and carbapenem resistant genes, and their co-existence in plasmid DNA of E. coli isolates in this study suggests the possible spread to other animal, human and environmental pathogens. Molecular methods in addition to the conventional diagnostics in laboratories can help in early diagnosis, effective management and control of their potential transmission.
“…In this study, urine constituted the highest frequency (28.2%) among all of the clinical samples. Our samples echo previous studies conducted in the International Friendship Hospital, Kathmandu [3], Universal College of Medical Sciences Bhairahawa [10], Human Organ Transplant Center [33], and Nobel Medical College, Biratnagar [35]. This may be due to the high association of Gram-negative bacteria with UTI, which is the most common among patients attending a hospital in Nepal [16].…”
Section: Overall Findingssupporting
confidence: 86%
“…Infections mediated by Gram-negative bacteria (GNB) constitute the major burden in low- and middle-income countries (LMICs) due to acquisition of various resistant genotypes. In particular, E. coli , K. pneumoniae , E. cloacae , and non-fermentative bacteria, such as P. vulgaris , A. baumannii , and Salmonella species, represent the major members of GNB that are associated with frequent and more severe forms of clinical manifestations, including urinary tract infection, bacteremia, and pneumonia [ 10 , 32 ]. More specifically, E. coli and K. pneumoniae represent the most predominant pathogens isolated from such infections [ 15 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…The emergence and spread of these drug-resistant genes can limit therapeutic options, increase morbidities and mortalities, prolong hospital stays, and cost massive economic loss [ 9 ]. Most of the low and middle income countries (LMICs), including Nepal, have poor infection control strategies, and lack of diagnostic facilities, routine monitoring, and surveillance systems for AMR [ 10 , 11 , 12 ]. In addition to this, wide availability and use of over-the-counter (OTC) antimicrobials are further aggravating the AMR in LMIC settings, including Nepal [ 13 ].…”
Background: Antimicrobial resistance (AMR) among Gram-negative pathogens, predominantly ESBL-producing clinical isolates, are increasing worldwide. The main aim of this study was to determine the prevalence of ESBL-producing clinical isolates, their antibiogram, and the frequency of ESBL genes (blaTEM and blaCTX-M) in the clinical samples from patients. Methods: A total of 1065 clinical specimens from patients suspected of heart infections were collected between February and August 2019. Bacterial isolates were identified on colony morphology and biochemical properties. Thus, obtained clinical isolates were screened for antimicrobial susceptibility testing (AST) using modified Kirby–Bauer disk diffusion method, while ESBL producers were identified by using a combination disk diffusion method. ESBL positive isolates were further assessed using conventional polymerase chain reaction (PCR) to detect the ESBL genes blaTEM and blaCTX-M. Results: Out of 1065 clinical specimens, 17.8% (190/1065) showed bacterial growth. Among 190 bacterial isolates, 57.4% (109/190) were Gram-negative bacteria. Among 109 Gram-negative bacteria, 40.3% (44/109) were E. coli, and 30.2% (33/109) were K. pneumoniae. In AST, 57.7% (n = 63) Gram-negative bacterial isolates were resistant to ampicillin and 47.7% (n = 52) were resistant to nalidixic acid. Over half of the isolates (51.3%; 56/109) were multidrug resistant (MDR). Of 44 E. coli, 27.3% (12/44) were ESBL producers. Among ESBL producer E. coli isolates, 58.4% (7/12) tested positive for the blaCTX-M gene and 41.6% (5/12) tested positive for the blaTEM gene. Conclusion: Half of the Gram-negative bacteria in our study were MDR. Routine identification of an infectious agent followed by AST is critical to optimize the treatment and prevent antimicrobial resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.